In the tumor microenvironment (TME), the role of CD8+ T cells can be enhanced by cancer immunotherapy, in turn, immunotherapy-activated CD8+ T cells release cytokines including interferon γ (IFNγ) [16]. This evidence concerns the gene IFNG and neoplasm.